Company fined over marketing claims

Mundipharma pays $302,400 in penalties over infringement notices related to marketing claims regarding nine opioid medicines Mundipharma has paid thousands of dollars in penalties in response to 24 infringement notices issued by the TGA. The infringement notices relate to a claim used in communications with health professionals regarding nine opioid medicines marketed under the brand